Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
With eligibility basics covered, the next step is understanding which medical conditions most often support using HSA and FSA funds for GLP-1
In the SURMOUNT-1 obesity trial, treatment discontinuation due to adverse events rose from 2.6% on placebo to 4.3% at 5 mg, 7.1% at 10 mg, and 6.2% at 15 mg
The bottom
Never share the pen between people, and avoid combining with other injectable medicines
Expanded FDA Indications In 2024/2025 The potential uses for GLP-1s are expanding rapidly, moving well beyond their original purpose of diabetes management
US$ 28.23
US$ 23.33
US$ 22.22
US$ 26.66
US$ 25.60
US$ 29.81
